The Valley Desk

ArticleNeuropsychiatric disease and treatmentPublished

Efficacy of Adjunctive Lumateperone 42 mg on Anhedonia and Across a Broad Range of Depressive Symptoms in Major Depressive Disorder: Post Hoc Analysis of a Phase 3, Randomized, Placebo-Controlled Trial

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Perelman School of Medicine, University of Pennsylvania. Affiliation source

Publication record

Type
Article
Venue
Neuropsychiatric disease and treatment
Published
Subject terms
Major Depressive Disorder; Antipsychotic; Lumateperone; Anhedonia Factor Score
PubMed ID
42344568
PubMed Central ID
PMC13289650
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal